BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15849179)

  • 1. The molecular perspective: l-asparaginase.
    Goodsell DS
    Stem Cells; 2005 May; 23(5):710-1. PubMed ID: 15849179
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of L-asparaginase induced prothrombotic state in acute lymphoblastic leukemia.
    Parma M; Belotti D; Pogliani EM
    Haematologica; 1996; 81(2):191. PubMed ID: 8641657
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
    Fadilah SA; Faridah I; Cheong SK
    Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
    Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
    Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
    [No Abstract]   [Full Text] [Related]  

  • 5. Monolith and coating enzymatic microreactors of L-asparaginase: kinetics study by MCE-LIF for potential application in acute lymphoblastic leukemia (ALL) treatment.
    Qiao J; Qi L; Mu X; Chen Y
    Analyst; 2011 May; 136(10):2077-83. PubMed ID: 21461410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
    Lim HL; Teo CP; Wong K; Kueh YK
    Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.
    Ylikangas P; Mononen I
    Anal Biochem; 2000 Apr; 280(1):42-5. PubMed ID: 10805519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia.
    Tomar S; Bakhshi S; Kabra SK; Arya LS
    Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625
    [No Abstract]   [Full Text] [Related]  

  • 9. The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?
    Pinheiro JP; Boos J
    Br J Haematol; 2004 Apr; 125(2):117-27. PubMed ID: 15059133
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
    Beinart G; Damon L
    Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately?
    Patil S; Coutsouvelis J; Spencer A
    Cancer Treat Rev; 2011 May; 37(3):202-7. PubMed ID: 20822851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
    Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
    Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular perspective: L-asparaginase.
    Goodsell DS
    Oncologist; 2005 Mar; 10(3):238-9. PubMed ID: 15793227
    [No Abstract]   [Full Text] [Related]  

  • 14. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
    Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
    Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
    Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
    Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
    Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mechanism of leukemia drug resistance?
    Williams DA
    N Engl J Med; 2007 Jul; 357(1):77-8. PubMed ID: 17611211
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erwinia asparaginase: coming closer to an understanding of its use in pediatric acute lymphoblastic leukemia?
    Maloney KW
    Pediatr Blood Cancer; 2010 Feb; 54(2):189-90. PubMed ID: 19967774
    [No Abstract]   [Full Text] [Related]  

  • 20. Turbid serum in a patient of acute lymphoblastic leukemia on treatment--what to look for?
    Singh T; Satheesh CT; Madhumathi DS; Goyal M; Rajeev LK; Lakshmaiah KC; Suresh TM; Babu KG
    J Cancer Res Ther; 2009; 5(3):219-20. PubMed ID: 19841569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.